For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

Scientific Program

PGP39

3508

Dr.Lekha Ravikumar
Membership No Author Name Email Mobile
4607MW Dr.Supritha K B suprithakb19977@gmail.com 8618374560
Cornea, Ocular Surface and External Eye Diseases

Povidone-iodine-loteprednol vs moxifloxacin dexamethasone in adenoviral conjunctivitis 

Purpose :Adenoviral conjunctivitis is a common, highly contagious ocular infection with limited effective treatment options. This study compared the safety and efficacy of topical povidone-iodine (PVP-I) 0.6%/loteprednol 0.5% and moxifloxacin 0.5%/dexamethasone 0.1%.
Methods:A prospective interventional comparative study was conducted from December 2025 to June 2026 in 58 patients aged >12 years with clinically diagnosed adenoviral conjunctivitis. Patients were alternately allocated to receive either regimen four times daily. Assessments were performed on day 3, week 1, and month 1. Safety, efficacy, and time to clinical resolution were compared.
Results:PVP-I/loteprednol showed earlier clinical resolution (6–9 days) compared with moxifloxacin/dexamethasone (1–2 weeks). Both regimens were well tolerated.
Conclusion:PVP-I 0.6%/loteprednol0.5% was well tolerated and associated with earlier clinical resolution compared with moxifloxacin 0.5%/dexamethasone0.1% in adenoviral conjunctivitis.

Membership No Author Name Email Mobile
3791 Dr.Chaithra C M chaithracm08@gmail.com 9035268295